Baerbel Rohrer
Company: MitoChem Therapeutics
Job title: Chief Executive Officer
Seminars:
Preserving Sight in Patients With Neurodegenerative Diseases Through a First-in-Class Target 3:15 pm
Highlighting the implications of mitochondrial dysfunction underlying the pathological basis for tissue damage in retinal diseases Building a library of mitochondrial protective compounds to design a new class of small molecules that can treat neurodegeneration through the protection of mitochondrial homeostasisRead more
day: CONFERENCE DAY ONE